Attention-Deficit Hyperactivity Disorder

However, the prevalence of cardiomyopathy in this population was less than 1%.

Patients diagnosed with celiac disease in childhood have a higher risk for psychiatric disorders with the increased risk persisting until adulthood, according to study results.

In 2008, the U.S. House of Representatives designated July as Bebe Moore Campbell National Minority Mental Health Awareness Month.

PHILADELPHIA — Children and adolescents with arrhythmia disorders are more likely to be diagnosed with depression, anxiety or ADHD than those without them, according to data presented at the American Heart Association Scientific Session.

Children with hypogonadotropic hypogonadism or delayed puberty are more likely to develop neurodevelopment disorders, such as autism spectrum disorder, ADHD and intellectual disabilities, compared with those who undergo normal puberty, according to findings published in the Journal of Neuroendocrinology.

ADHD affects approximately 11% of school-aged children every year, and this rate continues to rise annually. The primary treatment modality includes amphetamines and methylphenidate, with 82.5% of children being prescribed medication.

Female reproductive traits share a genetic link with certain psychiatric disorders in offspring, particularly ADHD, according to findings published in Scientific Reports.

Patients with autism spectrum disorder and co-occurring ADHD can safely and effectively take medication for ADHD, according to a study conducted in the Netherlands and published in Journal of Attention Disorders.

Tim Wilens, MD, chief of the division of child and adolescent psychiatry at Massachusetts General Hospital in Boston and professor of psychiatry at Harvard Medical School, spoke about the “exciting area” of recent findings on ADHD across patient lifespan in a video interview.

Children born to mothers with anxiety during pregnancy and a few years after birth were more likely to have hyperactivity when they were 16 years old, according to study findings presented at the European College of Neuropsychopharmacology Congress.